secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2025-09-23T23:59:59+00:00
Accession:  0001493152-25-014557
Event type: other_material
Sentiment:  positive
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical CEO to Discuss LIBERTY FDA Clearance and Commercialization on Benzinga Interview Sept 24
--------------------------------------------------------------------------------

- CEO Harel Gadot will be interviewed on Benzinga All Access at 10:45am ET on September 24, 2025.
- Discussion will cover recent FDA 510(k) clearance of the LIBERTY Endovascular Robotic System.
- FDA clearance for LIBERTY was announced on September 8, 2025.
- Company plans for U.S. commercialization of the peripheral endovascular system.
- LIBERTY is described as the first single-use, remotely operated robotic solution for endovascular procedures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000149315225014557/0001493152-25-014557-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000149315225014557/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-014557

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer